"/> Invitrogen™ Peptide synthétique ZMIZ1 humain | B-LABO France

Invitrogen™ Peptide synthétique ZMIZ1 humain

Réf. : BL-RE-175629Réf. fabricant : 15245249 50 μg
136,00 € HT

Synthetic Peptide

Gene ID (Entrez)
57178
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q9ULJ6
Nom usuel
Human ZMIZ1
Marque
Invitrogen

ZIMP10 Synthetic Peptide, PEP-1247, from Invitrogen.

Retinoic acid plays a critical role in development, cellular growth, and differentiation and induces the expression of a variety of genes. RAI17 expression is induced by retinoic acid and is predominantly expressed in heart, brain and ovaries. Within brain, highest expression is in amygdala. The deduced 1,067-amino acid protein contains an MSX-interacting zinc finger (MIZ) domain, a nuclear localization signal sequence, and 2 proline-rich regions. A strong intrinsic transactivation domain is identified in the C-terminal proline-rich region. RAI17 expression is detected in various cancer cell lines. RAI17 colocalizes with endogenous androgen receptor (AR) in the nuclei of prostate epithelial cells from human tissue samples. In human prostate cancer cells, RAI17 increases the transcriptional activity of AR. Studies using sumoylation-deficient AR mutants suggest that the increase of AR activity by RAI17 is dependent upon receptor sumoylation.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-175629
Réf. fabricant15245249
Gene ID (Entrez)57178
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ9ULJ6
Nom usuelHuman ZMIZ1
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)ZMIZ1
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.